{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:17:03Z","timestamp":1788283023610,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007337","name":"Massachusetts Eye and Ear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.037","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:25:47Z","timestamp":1782257147000},"page":"246-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-8175","authenticated-orcid":false,"given":"Owais","family":"Fazal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-4650","authenticated-orcid":false,"given":"Asad","family":"Loya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2830-9832","authenticated-orcid":false,"given":"Jawad","family":"Muayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer F.","family":"Alsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius D.","family":"Bordbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Chaaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Y.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-7078","authenticated-orcid":false,"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-6104","authenticated-orcid":false,"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2026.06.037_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.037_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cells9040910","article-title":"A G-protein coupled receptor and macular degeneration","volume":"9","author":"Figueroa","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajo.2026.06.037_bib0003","first-page":"1","article-title":"Dopaminergic therapies may decrease risk of early and intermediate non-exudative age-related macular degeneration progression","author":"Morgan","year":"2025","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"17","key":"10.1016\/j.ajo.2026.06.037_bib0004","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174199","article-title":"DRD2 activation inhibits choroidal neovascularization in patients with Parkinson\u2019s disease and age-related macular degeneration","volume":"134","author":"Mathis","year":"2024","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.037_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjmed.2015.10.015","article-title":"Mining retrospective data for virtual prospective drug repurposing: L-DOPA and age-related macular degeneration","volume":"129","author":"Brilliant","year":"2016","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.037_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.05.038","article-title":"Levodopa positively affects neovascular age-related macular degeneration","volume":"134","author":"Figueroa","year":"2021","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.037_bib0007","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.oret.2023.04.014","article-title":"Levodopa is associated with reduced development of neovascular age-related macular degeneration","volume":"7","author":"Hyman","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2026.06.037_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/24741264251330338","article-title":"Possible association between dopamine antagonists and increased conversion to exudative age-related macular degeneration","author":"Weng","year":"2025","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.ajo.2026.06.037_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147247","article-title":"Mechanism of circular RNA-mediated regulation of L-DOPA to improve wet age-related macular degeneration","volume":"861","author":"Jia","year":"2023","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.037_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40662-024-00412-2","article-title":"Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degeneration","volume":"11","author":"Chan","year":"2024","journal-title":"Eye Vis"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.037_bib0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.037_bib0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"19","key":"10.1016\/j.ajo.2026.06.037_bib0013","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2026.06.037_bib0014","first-page":"467","article-title":"Roles of drug transporters in blood-retinal barrier","volume":"1141","author":"Liu","year":"2019","journal-title":"Drug Transp Drug Dispos Eff Toxic"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:34:08Z","timestamp":1788280448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"alternative-id":["S0002939426003466"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.037","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}